Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
MRVI: Maravai LifeSciences Holdings, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
MRVI
The Story
MRVI
Loading chart data...
Current State
Balance holding
The verdict
Good business
Mixed
Revenue growth
-10.3% / yr
Operating margin
21.9%
ROIC
6.5%
Financially safe
Adequate
Debt / equity
1.28×
Interest coverage
1.7×
Current ratio
5.91×
Maravai LifeSciences Holdings, Inc.
MRVI
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Maravai LifeSciences Holdings, Inc.
MRVI
NASDAQ
·
USD
·
Closed
$6.57
−2.67%
$6.57
−$0.18 (2.67%)
52W Range
84th
pctl
Volume
0.35×
avg
Mkt Cap
1.81B
USD
P/E
-9.1
TTM
Div Yield
–
ann
52W Range
84th
pctl
Volume
0.35×
avg
Market Cap
1.81B
USD
P/E Ratio
-9.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings